Polycystic ovary syndrome and cardiovascular risk profile

被引：0
|
作者：
Bohlen, Sophia-Marie [1 ]
Kiesel, Ludwig [2 ]
机构：
[1] A&P MVZ GmbH, Pruner Gang 7, D-24103 Kiel, Germany
[2] Univ Klinikum Munster, Klin Frauenheilkunde & Geburtshilfe, Munster, Germany
来源：
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2024年 / 22卷 / 03期
关键词：
DIAGNOSTIC-CRITERIA; INSULIN-RESISTANCE; METABOLIC SYNDROME; WOMEN; EPIDEMIOLOGY; HYPERTENSION; PREVALENCE; PREDICTORS; FEATURES;
D O I：
10.1007/s10304-024-00569-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：216 / 220
页数：5
相关论文
共 50 条
  • [21] Risk of cardiovascular events in patients with polycystic ovary syndrome
    Iftikhar, S.
    Collazo-Clavell, M. L.
    Roger, V. L.
    St Sauver, J.
    Brown, R. D., Jr.
    Cha, S.
    Rhodes, D. J.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (02): : 74 - 80
  • [22] Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
    Armeni, Eleni
    Lambrinoudaki, Irene
    CURRENT VASCULAR PHARMACOLOGY, 2019, 17 (06) : 579 - 590
  • [23] Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Uestuen, Yaprak
    Ustun, Yusuf
    Meydanli, M. Mutlu
    Kafkasli, Ayse
    Yetkin, Guelay
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (06) : 324 - 328
  • [24] Cardiovascular disease risk in offspring of polycystic ovary syndrome
    Shawky, Noha M.
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] Study of cardiovascular risk factors in polycystic ovary syndrome
    Hari, A.
    Murthy, N. L. N.
    Mahesh, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 55 - 55
  • [26] Cardiovascular Risk in the Different Phenotypes of Polycystic Ovary Syndrome
    Tziomalos, Konstantinos
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (36) : 5547 - 5553
  • [27] Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome
    Lambrinoudaki, Irene
    MATURITAS, 2011, 68 (01) : 13 - 16
  • [28] Cardiovascular risk profile in polycystic ovarian syndrome
    Tan, S
    Hahn, S
    Sack, S
    Benson, S
    Schmidt, M
    Kimmig, R
    Elsenbruch, S
    Erbel, R
    Mann, K
    Janssen, OE
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A13 - A14
  • [29] Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
    Alalami, Huda
    Sathyapalan, Thozhukat
    Atkin, Stephen L.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 10
  • [30] Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome
    E. Carmina
    Journal of Endocrinological Investigation, 2013, 36 : 358 - 363
12345